Scientometrics
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Feb 27, 2021; 13(2): 210-221
Published online Feb 27, 2021. doi: 10.4240/wjgs.v13.i2.210
Nine-long non-coding ribonucleic acid signature can improve the survival prediction of colorectal cancer
Zhen Zong, Ce-Gui Hu, Tai-Cheng Zhou, Zhuo-Min Yu, Fu-Xin Tang, Hua-Kai Tian, Hui Li, He Wang
Zhen Zong, Ce-Gui Hu, Hua-Kai Tian, Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China
Tai-Cheng Zhou, Zhuo-Min Yu, Fu-Xin Tang, Department of Gastrointestinal Surgery and Hernia Center, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, Guangdong Province, China
Hui Li, Department of Rheumatology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China
He Wang, Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China
Author contributions: Zong Z and Hu CG contributed equally to this work; Wang H and Li H were both corresponding authors; Zong Z, Zhou TC, and Tang FX were responsible for study conception and design; Wang H, Tian HK, and Yu ZM were responsible for the provision of study materials or patients; Li H and Hu CG were responsible for data analysis and interpretation; All authors were responsible for manuscript writing and final approval of manuscript.
Supported by National Natural Science Foundation of China, No. 81860433; the Natural Science Youth Foundation of Jiangxi Province, No. 20192BAB215036; the Foundation for Fostering Young Scholar of Nanchang University, No. PY201822; National Natural Science Foundation of China, No. 81960359; and the Key Technology Research and Development Program of Jiangxi Province, No. 20202BBG73024.
Conflict-of-interest statement: The authors declare that they have no competing interests.
PRISMA 2009 Checklist statement: The authors confirm that the manuscript was prepared according to the PRISMA 2009 checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: He Wang, MD, PhD, Chief Doctor, Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang 330006, Jiangxi Province, China. wanghe2000@163.com
Received: July 11, 2020
Peer-review started: July 11, 2020
First decision: November 16, 2020
Revised: November 30, 2020
Accepted: December 17, 2020
Article in press: December 17, 2020
Published online: February 27, 2021
Processing time: 208 Days and 10.6 Hours
Core Tip

Core Tip: To the best of our knowledge, preliminary investigation of the function of this nine-long non-coding ribonucleic acid signature has not been reported, which further strengthens the possibility it may be used to effectively predict the disease course in colorectal cancer.